SJD Barcelona Children’s Hospital
SJD Barcelona Children’s Hospital
Hiszpania, Barcelona
Tylko dzieci i młodzież (0-18 lat)
Akredytacje :
Lymphoma treatment cost in Spain typically starts with essential diagnostics like a PET/CT scan, which runs from $1,100 to $1,600. Primary treatment options like chemotherapy range from $2,500 to $4,500, while advanced CAR T-cell therapy costs between $330,000 and $420,000. Total expenses depend on the lymphoma stage and protocol, with savings of 30-50% compared to the US. Top cities for care include Barcelona and Madrid.
Typical Lymphoma Treatment Costs in Spain
Bookimed Expert Insight: Pediatric patients require specialized molecular diagnostics found at top-tier centers like SJD Barcelona Children’s Hospital. For complex adult cases, JCI-accredited facilities such as Centro Médico Teknon provide advanced robotized technologies. Patients seeking innovative research benefit from Quironsalud Madrid, which offers clinical trials for cancer. For high-volume surgical expertise, Hospital Universitario HM Madrid manages over 26,000 annual operations with multidisciplinary teams.
| Turcja | Austria | Hiszpania | |
| Terapia komórkami CAR-T | od $150,000 | od $350,000 | od $330,000 |
| Terapia biologiczna | od $5,500 | od $20,000 | od $15,000 |
| Radioterapia raka odbytnicy | od $7,000 | od $12,000 | od $10,000 |
| Przeszczepienie szpiku kostnego allogeniczne od dawcy spokrewnionego | od $65,000 | od $150,000 | od $13,826 |
| Przeszczep szpiku kostnego | od $36,000 | od $140,000 | od $71,782 |
Specjalista w zakresie przeszczepiania szpiku kostnego – dr Rives Sola wnosi specjalistyczną wiedzę w leczenie chłoniaków u dzieci w szpitalu dziecięcym SJD Barcelona.
Dr Graupera jest uznanym onkologiem dziecięcym i kieruje Oddziałem Hematologii i Onkologii w Sant Joan De Déu – jednym z najlepszych szpitali dziecięcych w Europie.
Dr Francesc Cobo Valien specjalizuje się w leczeniu chłoniaków w Centro Médico Teknon, mając na koncie ponad 1100 przeprowadzonych zabiegów.
Profesor Bosch jest światowej sławy liderem w badaniach nad przewlekłą białaczką limfocytową (PBL) i chłoniakami, prowadzącym ponad 80 aktywnych badań klinicznych.
Spain offers advanced lymphoma treatments including academic CAR T-cell therapy, allogeneic stem cell transplantation, and targeted immunotherapy. Specialized hematology units in Barcelona and Madrid provide personalized protocols. Centers like Hospital Quiron Barcelona and Centro Medico Teknon utilize molecular diagnostics to guide treatment selection.
Bookimed Expert Insight: While CAR-T therapy is often associated with high costs, Spain stands out due to its unique development of academic programs like ARI-0001. Our data shows that centers such as Clinica Universidad de Navarra are among the first to receive JCI accreditation for these complex procedures. For pediatric cases, Sant Joan de Deu Barcelona serves 450,000 patients annually, offering rare access to specialized molecular medicine laboratories for precise tumor staging.
Patient Consensus: Patients emphasize finding a doctor who actively manages clinical trials, as these provide access to novel drugs not yet in routine use. Reviewers frequently note that having an international patient coordinator like those at HM Hospitales helps manage the logistics of long-term treatments.
Spanish hematology centers report high success rates for lymphoma treatment. Hodgkin lymphoma cure rates reach approximately 80% with modern protocols. Non-Hodgkin lymphoma chemotherapy efficacy ranges between 70% and 90%. Advanced CAR T-cell therapies show response rates up to 80% for resistant cases in leading Barcelona institutions.
Bookimed Expert Insight: While many choose major hubs, Clinica Universidad de Navarra stands out as the first Spanish hospital to receive JCI accreditation. It maintains a 95% patient satisfaction rate. This suggests that their integrated academic approach effectively balances clinical success with high-quality patient care in complex hematology cases.
Patient Consensus: Patients note it is important to choose a clinic with extensive clinical trial access. They often highlight the comfort of having meals included during long hospital stays at centers like Quironsalud Madrid.
Barcelona and Madrid are Spain's primary hubs for advanced lymphoma treatment. Top institutions like Centro Medico Teknon and Quironsalud Madrid offer CAR T-cell therapy and bone marrow transplants. These centers hold Joint Commission International (JCI) accreditation and feature specialists with experience in over 1,000 procedures.
Bookimed Expert Insight: Spain’s leadership in lymphoma care is driven by high patient volumes and clinical research access. Quironsalud Madrid serves more patients annually than most European hospitals. Patients there can often access new lymphoma drugs for free by participating in clinical trials. This makes Spain a strategic choice for cases resistant to standard chemotherapy.
Patient Consensus: Patients note that Spanish hospitals provide a very calm and supportive atmosphere. They highlight that doctors explain every step of the biopsy and transplant process in simple terms.
Lymphoma treatment in Spain typically lasts 2 to 8 months depending on the subtype and stage. Early-stage Hodgkin lymphoma schedules often span 2 to 4 months. More intensive regimens for advanced Non-Hodgkin lymphoma generally require 6 to 8 months for completion within Spanish oncology centers.
Bookimed Expert Insight: Spanish private centers significantly compress the diagnostic timeline compared to public systems. While public queues may delay treatment for weeks, top-tier clinics in Barcelona and Madrid leverage in-house PET-CT and molecular labs to move from biopsy to the first chemotherapy cycle in under 7 days. This accelerated sequencing can shave up to 2 months off the total journey from first visit to remission.
Patient Consensus: Patients note that choosing private care in Barcelona or Madrid often slashes wait times by 50%. Many emphasize the importance of having a helpful international coordinator to navigate the hospital bureaucracy quickly.
International patients can join lymphoma clinical trials in Spain if they meet eligibility and obtain sponsor approval. Specialized institutions like Clinica Universidad de Navarra and Quironsalud Madrid manage complex protocols. Participation in the trial and investigative drugs is free for eligible participants.
Bookimed Expert Insight: Quironsalud Madrid stands out because it offers free treatment for qualifying clinical trial participants. This is a significant finding given its high volume and Newsweek certification. This clinic remains the largest in its network. It is a strategic choice for patients seeking research-based care in Madrid.
Patient Consensus: Patients mention the help of multilingual coordinators at centers like HM Hospitales. They note that having a dedicated coordinator helps manage logistics while focusing on treatment.
Spain provides wide access to CAR T-cell therapy for adults and children. Specialized centers in Barcelona and Madrid offer both commercial and academic treatments. Authorized indications include relapsed B-cell leukemia for patients under 25 and several lymphoma types for adults. Coverage is available through public and private sectors.
Bookimed Expert Insight: Spain has a unique advantage with academic CAR-T products developed by public institutions. These academic versions can cost under $90,000. This is significantly lower than commercial products like Kymriah. Patients often access these through centers like Clinica Universidad de Navarra. This clinic was the first in Spain to receive JCI accreditation.
Patient Consensus: Patients note that pediatric access is concentrated in major cities like Barcelona. Moving fast is vital because manufacturing the cells often takes 4 to 6 weeks.
Spanish centers like Quironsalud Madrid and Centro Medico Teknon offer extensive outpatient lymphoma services. Patients receive chemotherapy, targeted biotherapy, and CAR T-cell therapy in day-care units. JCI-accredited facilities provide supportive programs including fertility preservation, psychological counseling, and specialized pediatric oncology care.
Bookimed Expert Insight: Spanish centers show a high specialization in pediatric blood cancers. SJD Barcelona Children's Hospital and HM Hospitales both feature dedicated pediatric units led by directors with experience at US institutions like Memorial Sloan Kettering. This allows international patients to access protocols usually reserved for academic research centers while staying in a family-oriented outpatient setting.
Patient Consensus: Patients highlight that day-clinic sessions can last up to 8 hours. They note it's important to bring snacks and entertainment. Many emphasize that having an international coordinator like Maya at HM Hospitales makes navigating the treatment process much smoother.